Pathway Enlargement Enrichment results for KEGG

Cancer-type	Pathway	Q-value	P-value	Pathway size	Cancer set size	DP	DN	GP	GN
parson_gbm	hsa04510:Focal adhesion	6.1e-16	4.36e-18	259	301	45	256	259	8681
parson_gbm	hsa04810:Regulation of actin cytoskeleton	1.82e-09	2.6e-11	233	301	33	268	233	8707
parson_gbm	hsa05222:Small cell lung cancer	2.87e-08	6.15e-10	117	301	22	279	117	8823
parson_gbm	hsa04012:ErbB signaling pathway	6.1e-08	1.74e-09	190	301	27	274	190	8750
parson_gbm	hsa05215:Prostate cancer	1.70e-07	7.02e-09	123	301	21	280	123	8817
parson_gbm	hsa05213:Endometrial cancer	1.70e-07	7.27e-09	77	301	17	284	77	8863
parson_gbm	hsa04512:ECM-receptor interaction	1.36e-06	6.78e-08	80	301	16	285	80	8860
parson_gbm	hsa05214:Glioma	1.67e-06	9.53e-08	94	301	17	284	94	8846
parson_gbm	hsa04670:Leukocyte transendothelial migration	5.71e-06	3.67e-07	131	301	19	282	131	8809
parson_gbm	hsa05218:Melanoma	5.89e-06	4.21e-07	81	301	15	286	81	8859
parson_gbm	hsa05212:Pancreatic cancer	8.49e-06	6.67e-07	123	301	18	283	123	8817
parson_gbm	hsa05210:Colorectal cancer	2.39e-05	2.05e-06	120	301	17	284	120	8820
parson_gbm	hsa05223:Non-small cell lung cancer	4.81e-05	4.47e-06	87	301	14	287	87	8853
parson_gbm	hsa04910:Insulin signaling pathway	5.09e-05	5.09e-06	144	301	18	283	144	8796
parson_gbm	hsa05219:Bladder cancer	5.12e-05	5.49e-06	64	301	12	289	64	8876
parson_gbm	hsa05220:Chronic myeloid leukemia	5.53e-05	6.53e-06	132	301	17	284	132	8808
parson_gbm	hsa04020:Calcium signaling pathway	5.53e-05	6.99e-06	163	301	19	282	163	8777
parson_gbm	hsa01430:Cell Communication	5.53e-05	7.11e-06	91	301	14	287	91	8849
parson_gbm	hsa05221:Acute myeloid leukemia	8.36e-05	1.14e-05	82	301	13	288	82	8858
parson_gbm	hsa04514:Cell adhesion molecules (CAMs)	0.000144	2.06e-05	101	301	14	287	101	8839
parson_gbm	hsa04070:Phosphatidylinositol signaling system	0.000246	3.69e-05	54	301	10	291	54	8886
parson_gbm	hsa04320:Dorso-ventral axis formation	0.000292	4.59e-05	44	301	9	292	44	8896
parson_gbm	hsa04330:Notch signaling pathway	0.000651	0.000110	50	301	9	292	50	8890
parson_gbm	hsa02010:ABC transporters - General	0.000651	0.000119	19	301	6	295	19	8921
parson_gbm	hsa04530:Tight junction	0.000651	0.000123	121	301	14	287	121	8819
parson_gbm	hsa04150:mTOR signaling pathway	0.000651	0.000125	51	301	9	292	51	8889
parson_gbm	hsa05217:Basal cell carcinoma	0.000651	0.000125	51	301	9	292	51	8889
parson_gbm	hsa00020:Citrate cycle (TCA cycle)	0.000754	0.000151	20	301	6	295	20	8920
parson_gbm	hsa04730:Long-term depression	0.00094	0.000195	96	301	12	289	96	8844
parson_gbm	hsa04520:Adherens junction	0.00105	0.000225	113	301	13	288	113	8827
parson_gbm	hsa05211:Renal cell carcinoma	0.00124	0.000275	100	301	12	289	100	8840
parson_gbm	hsa04662:B cell receptor signaling pathway	0.00163	0.000378	74	301	10	291	74	8866
parson_gbm	hsa04360:Axon guidance	0.00163	0.000384	120	301	13	288	120	8820
parson_gbm	hsa04370:VEGF signaling pathway	0.00176	0.000426	90	301	11	290	90	8850
parson_gbm	hsa04620:Toll-like receptor signaling pathway	0.00177	0.000444	122	301	13	288	122	8818
parson_gbm	hsa04610:Complement and coagulation cascades	0.00178	0.000458	76	301	10	291	76	8864
parson_gbm	hsa04930:Type II diabetes mellitus	0.00203	0.000536	50	301	8	293	50	8890
parson_gbm	hsa04080:Neuroactive ligand-receptor interaction	0.0023	0.000624	216	301	18	283	216	8724
parson_gbm	hsa04010:MAPK signaling pathway	0.00237	0.000659	275	301	21	280	275	8665
parson_gbm	hsa00650:Butanoate metabolism	0.00258	0.000736	18	301	5	296	18	8922
parson_gbm	hsa00561:Glycerolipid metabolism	0.00309	0.000905	19	301	5	296	19	8921
parson_gbm	hsa04210:Apoptosis	0.00331	0.000994	117	301	12	289	117	8823
parson_gbm	hsa04540:Gap junction	0.00387	0.00119	103	301	11	290	103	8837
parson_gbm	hsa04720:Long-term potentiation	0.00409	0.00129	88	301	10	291	88	8852
parson_gbm	hsa00252:Alanine and aspartate metabolism	0.00413	0.00133	21	301	5	296	21	8919
parson_gbm	hsa00620:Pyruvate metabolism	0.00573	0.00188	23	301	5	296	23	8917
parson_gbm	hsa04630:Jak-STAT signaling pathway	0.00806	0.00271	133	301	12	289	133	8807
parson_gbm	hsa00562:Inositol phosphate metabolism	0.00824	0.00283	38	301	6	295	38	8902
parson_gbm	hsa04310:Wnt signaling pathway	0.0148	0.00516	145	301	12	289	145	8795
parson_gbm	hsa04664:Fc epsilon RI signaling pathway	0.0175	0.00639	112	301	10	291	112	8828
parson_gbm	hsa04660:T cell receptor signaling pathway	0.0175	0.00639	112	301	10	291	112	8828
parson_gbm	hsa04650:Natural killer cell mediated cytotoxicity	0.0207	0.00769	134	301	11	290	134	8806
parson_gbm	hsa04115:p53 signaling pathway	0.0210	0.00811	64	301	7	294	64	8876
parson_gbm	hsa05030:Amyotrophic lateral sclerosis (ALS)	0.0210	0.00813	21	301	4	297	21	8919
parson_gbm	hsa05216:Thyroid cancer	0.0210	0.00824	34	301	5	296	34	8906
parson_gbm	hsa03030:DNA polymerase	0.0234	0.00936	22	301	4	297	22	8918
parson_gbm	hsa00010:Glycolysis / Gluconeogenesis	0.0367	0.0149	40	301	5	296	40	8900
parson_gbm	hsa03022:Basal transcription factors	0.0374	0.0155	26	301	4	297	26	8914
parson_gbm	hsa00280:Valine, leucine and isoleucine degradation	0.0393	0.0166	14	301	3	298	14	8926
parson_gbm	hsa01510:Neurodegenerative Diseases	0.0438	0.0188	59	301	6	295	59	8881
parson_gbm	hsa01032:Glycan structures - degradation	0.0439	0.0194	15	301	3	298	15	8925
parson_gbm	hsa00640:Propanoate metabolism	0.0439	0.0194	15	301	3	298	15	8925
parson_gbm	hsa04614:Renin-angiotensin system	0.05	0.0225	16	301	3	298	16	8924
parson_gbm	hsa05130:Pathogenic Escherichia coli infection - EHEC	0.0524	0.0243	81	301	7	294	81	8859
parson_gbm	hsa05131:Pathogenic Escherichia coli infection - EPEC	0.0524	0.0243	81	301	7	294	81	8859
parson_gbm	hsa04916:Melanogenesis	0.0567	0.0269	102	301	8	293	102	8838
parson_gbm	hsa04350:TGF-beta signaling pathway	0.0567	0.0271	122	301	9	292	122	8818
parson_gbm	hsa04060:Cytokine-cytokine receptor interaction	0.0568	0.0276	229	301	14	287	229	8711
parson_gbm	hsa05010:Alzheimer's disease	0.0636	0.0313	33	301	4	297	33	8907
parson_gbm	hsa05020:Parkinson's disease	0.0657	0.0333	19	301	3	298	19	8921
parson_gbm	hsa00600:Sphingolipid metabolism	0.0657	0.0333	19	301	3	298	19	8921
parson_gbm	hsa00564:Glycerophospholipid metabolism	0.0664	0.0341	34	301	4	297	34	8906
parson_gbm	hsa04340:Hedgehog signaling pathway	0.0672	0.035	51	301	5	296	51	8889
parson_gbm	hsa00230:Purine metabolism	0.0696	0.0368	89	301	7	294	89	8851
parson_gbm	hsa00500:Starch and sucrose metabolism	0.075	0.0402	36	301	4	297	36	8904
parson_gbm	hsa00251:Glutamate metabolism	0.0854	0.0464	22	301	3	298	22	8918
parson_gbm	hsa00511:N-Glycan degradation	0.0871	0.0479	9	301	2	299	9	8931
parson_gbm	hsa04742:Taste transduction	0.0919	0.0512	23	301	3	298	23	8917
parson_gbm	hsa04120:Ubiquitin mediated proteolysis	0.101	0.0574	120	301	8	293	120	8820
parson_gbm	hsa04110:Cell cycle	0.101	0.058	164	301	10	291	164	8776
parson_gbm	hsa00410:beta-Alanine metabolism	0.111	0.0651	11	301	2	299	11	8929
parson_gbm	hsa00903:Limonene and pinene degradation	0.111	0.0651	11	301	2	299	11	8929
parson_gbm	hsa00590:Arachidonic acid metabolism	0.133	0.0787	28	301	3	298	28	8912
parson_gbm	hsa00910:Nitrogen metabolism	0.14	0.084	13	301	2	299	13	8927
parson_gbm	hsa00220:Urea cycle and metabolism of amino groups	0.155	0.094	14	301	2	299	14	8926
parson_gbm	hsa04912:GnRH signaling pathway	0.168	0.103	115	301	7	294	115	8825
parson_gbm	hsa04920:Adipocytokine signaling pathway	0.17	0.106	72	301	5	296	72	8868
parson_gbm	hsa00240:Pyrimidine metabolism	0.173	0.109	52	301	4	297	52	8888
parson_gbm	hsa00710:Carbon fixation	0.181	0.115	16	301	2	299	16	8924
parson_gbm	hsa03320:PPAR signaling pathway	0.191	0.126	35	301	3	298	35	8905
parson_gbm	hsa04140:Regulation of autophagy	0.191	0.126	17	301	2	299	17	8923
parson_gbm	hsa00565:Ether lipid metabolism	0.191	0.126	17	301	2	299	17	8923
parson_gbm	hsa05040:Huntington's disease	0.199	0.133	36	301	3	298	36	8904
parson_gbm	hsa04640:Hematopoietic cell lineage	0.199	0.133	78	301	5	296	78	8862
parson_gbm	hsa00071:Fatty acid metabolism	0.202	0.137	18	301	2	299	18	8922
parson_gbm	hsa04740:Olfactory transduction	0.216	0.148	19	301	2	299	19	8921
parson_gbm	hsa00260:Glycine, serine and threonine metabolism	0.231	0.160	20	301	2	299	20	8920
parson_gbm	hsa00330:Arginine and proline metabolism	0.279	0.195	23	301	2	299	23	8917
parson_gbm	hsa00790:Folate biosynthesis	0.293	0.207	24	301	2	299	24	8916
parson_gbm	hsa00310:Lysine degradation	0.307	0.219	25	301	2	299	25	8915
parson_gbm	hsa05120:Epithelial cell signaling in Helicobacter pylori infection	0.325	0.235	72	301	4	297	72	8868
parson_gbm	hsa00380:Tryptophan metabolism	0.384	0.28	30	301	2	299	30	8910
parson_gbm	hsa00120:Bile acid biosynthesis	0.415	0.305	10	301	1	300	10	8930
parson_gbm	hsa00360:Phenylalanine metabolism	0.429	0.328	11	301	1	300	11	8929
parson_gbm	hsa00591:Linoleic acid metabolism	0.429	0.328	11	301	1	300	11	8929
parson_gbm	hsa00740:Riboflavin metabolism	0.429	0.328	11	301	1	300	11	8929
parson_gbm	hsa00361:gamma-Hexachlorocyclohexane degradation	0.429	0.328	11	301	1	300	11	8929
parson_gbm	hsa05060:Prion disease	0.454	0.35	12	301	1	300	12	8928
parson_gbm	hsa00512:O-Glycan biosynthesis	0.477	0.371	13	301	1	300	13	8927
parson_gbm	hsa01030:Glycan structures - biosynthesis 1	0.479	0.376	38	301	2	299	38	8902
parson_gbm	hsa04710:Circadian rhythm	0.485	0.392	14	301	1	300	14	8926
parson_gbm	hsa03020:RNA polymerase	0.485	0.392	14	301	1	300	14	8926
parson_gbm	hsa00150:Androgen and estrogen metabolism	0.485	0.392	14	301	1	300	14	8926
parson_gbm	hsa00980:Metabolism of xenobiotics by cytochrome P450	0.505	0.412	15	301	1	300	15	8925
parson_gbm	hsa00340:Histidine metabolism	0.52	0.431	16	301	1	300	16	8924
parson_gbm	hsa00480:Glutathione metabolism	0.52	0.431	16	301	1	300	16	8924
parson_gbm	hsa00052:Galactose metabolism	0.533	0.449	17	301	1	300	17	8923
parson_gbm	hsa00510:N-Glycan biosynthesis	0.533	0.449	17	301	1	300	17	8923
parson_gbm	hsa01031:Glycan structures - biosynthesis 2	0.55	0.467	18	301	1	300	18	8922
parson_gbm	hsa03050:Proteasome	0.622	0.534	22	301	1	300	22	8918
parson_gbm	hsa00350:Tyrosine metabolism	0.635	0.549	23	301	1	300	23	8917
parson_gbm	hsa04940:Type I diabetes mellitus	0.737	0.642	30	301	1	300	30	8910
parson_gbm	hsa04130:SNARE interactions in vesicular transport	0.757	0.665	32	301	1	300	32	8908
parson_gbm	hsa03010:Ribosome	0.849	0.752	41	301	1	300	41	8899
parson_gbm	hsa04612:Antigen processing and presentation	0.972	0.868	60	301	1	300	60	8880
parson_gbm	hsa05050:Dentatorubropallidoluysian atrophy (DRPLA)	1	1	18	301	0	301	18	8922
parson_gbm	hsa04950:Maturity onset diabetes of the young	1	1	18	301	0	301	18	8922
parson_gbm	hsa00440:Aminophosphonate metabolism	1	1	10	301	0	301	10	8930
parson_gbm	hsa00100:Biosynthesis of steroids	1	1	11	301	0	301	11	8929
parson_gbm	hsa00860:Porphyrin and chlorophyll metabolism	1	1	13	301	0	301	13	8927
parson_gbm	hsa05110:Cholera - Infection	1	1	28	301	0	301	28	8912
parson_gbm	hsa00970:Aminoacyl-tRNA biosynthesis	1	1	18	301	0	301	18	8922
parson_gbm	hsa00626:Naphthalene and anthracene degradation	1	1	10	301	0	301	10	8930
parson_gbm	hsa00051:Fructose and mannose metabolism	1	1	22	301	0	301	22	8918
parson_gbm	hsa00632:Benzoate degradation via CoA ligation	1	1	9	301	0	301	9	8931
parson_gbm	hsa00030:Pentose phosphate pathway	1	1	18	301	0	301	18	8922
parson_gbm	hsa00450:Selenoamino acid metabolism	1	1	13	301	0	301	13	8927
parson_gbm	hsa00930:Caprolactam degradation	1	1	10	301	0	301	10	8930
parson_gbm	hsa00530:Aminosugars metabolism	1	1	13	301	0	301	13	8927
parson_gbm	hsa00190:Oxidative phosphorylation	1	1	49	301	0	301	49	8891